Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC for Late Stage Chronic Spinal Cord Injury
NCT03505034Phase 2Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2019
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in spinal cord injury (SCI) comparing Umbilical Cord Mesenchymal Stem Cells with Placebo (2 arms). Primary endpoint: American Spinal Injury Association Score Scale at 12 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT03505034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03505034.